In cancer, CTLA-4 expression is induced in T cells after TCR activation and its signaling starts when APCs migrate from cancer to draining lymph nodes, here presenting the tumour-associated antigen to T lymphocytes, replacing CD28 by the interaction with B7 ligands [14]. This evidence concerns the gene CTLA4 and cancer.